IN8bio, Inc. (INAB) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.93
+12.06%
Mkt Cap $8.39M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $16.00M | — | — | -$0.18 | -$0.26 | -44.44% |
| Q4 2025 Nov 6, 2025 | — | — | — | -$1.20 | -$0.85 | +29.17% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$1.50 | -$1.24 | +17.33% |
| Q2 2025 May 7, 2025 | — | — | — | -$1.80 | -$2.10 | -16.67% |
| Q1 2025 Mar 13, 2025 | — | — | — | -$0.07 | -$0.04 | +42.86% |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.14 | -$0.15 | -7.14% |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.16 | -$0.19 | -18.75% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.17 | -$0.20 | -17.65% |
| Q1 2024 Mar 14, 2024 | — | $3.75M | — | -$0.16 | -$0.21 | -31.25% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.25 | -$0.23 | +8.00% |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.28 | -$0.27 | +3.57% |
| Q2 2023 May 12, 2023 | — | — | — | -$0.33 | -$0.30 | +9.09% |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.28 | -$0.32 | -14.29% |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.28 | -$0.34 | -21.43% |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.33 | -$0.38 | -15.15% |
| Q2 2022 May 12, 2022 | — | — | — | -$0.34 | -$0.33 | +2.94% |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.21 | -$0.21 | +0.00% |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.33 | -$0.25 | +24.24% |
| Q3 2021 Sep 10, 2021 | — | — | — | -$0.30 | -$0.16 | +45.79% |
| Q3 2021 Jul 30, 2021 | — | — | — | — | -$0.16 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.12 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.09 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.19 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.11 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.48 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$0.48 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$0.16 | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$0.16 | — |
| Q2 2018 Jun 30, 2018 | — | — | — | — | -$0.08 | — |
| Q1 2018 Mar 31, 2018 | — | — | — | — | -$0.08 | — |